If you can read this text, your browser does not support Cascading Style Sheets. Although not essential for using this CD-ROM, you may wish to upgrade your browser to a more recent version.
Thursday, February 22, 2007
7:20am – 5:30pm
0001 – Military Allergy/Immunology Program – 21st Annual Harold S. Nelson Allergy/Immunology Symposium
Welcome and Overview
Emerging Infectious Diseases for the Immunologist
Vaccine Healthcare Center Update
Military Aeroallergen Extract Laboratory Updates
Military Allergy/Immunology Program – 21st Annual Harold S. Nelson Allergy/Immunology Symposium
Consultants to the Surgeons General Update – Air Force
Consultants to the Surgeons General Update – Army
Consultants to the Surgeons General Update – Navy
Friday, February 23, 2007
7:00 – 10:30am
1001 – FIT Breakfast Symposium
Introductory Remarks
The "Basics" of Adhesion Molecules
Anti – Adhesion Molecule Therapy in Allergic Disease
10:40 – 11:50am
1002 – FIT Morning Symposium
Aspirin Sensitivity
Rhinosinusitis: Diagnosis and Treatment
12:15 – 1:45pm
1003 – FIT Lunch Symposium
Academia
Academia
Private Practice
7:00 – 8:30am
1011 – Clinical Research (CR) Workshop: Site and Investigator Selection
Site and Investigator Selection
1012 – Clinical Research (CR) Workshop: FDA Audits
The Clinical Site and IRB Perspectives on FDA Audits
The FDA Perspective on Auditing a Clinical Trial Site Presentation
1013 – Clinical Research (CR) Workshop: Ethics in Clinical Research
Clinical Research (CR) Workshop: Ethics in Clinical Research
Clinical Research (CR) Workshop: Ethics in Clinical Research
1014 – Clinical Research (CR) Workshop: Is Your Investigative Site in Compliance with Good Clinical Practice
9:00am – 12:00pm
1101 – Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 1)
Importance of Phenotype Assessment in Genetic Studies: The Coast Study
New Approaches in Family and Population Studies in Allergy and Asthma
Gene Identification and Expression Studies in Allergy and Asthma
Gene – Environment Interactions: Specific Lessons from the Cincinnati Birth Cohort Study
1102 – Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part I)
Overview: Why Are Patients Nonadherent?
Clinical Management Strategies to Promote Adherence of Pediatric Asthma Patients and Families
Communication Skills That Will Yield Positive Outcomes
The Role of Motivational Interviewing to Help Guide Patients to Favorable Asthma Management Actions
The Value of Adherence Monitoring Strategies for Both Low and High – Risk Patients
1103 – Protective Effects of Infections and Microbial Exposures on Allergic Diseases
Epidemiology of Infections and Allergic Diseases
Role of Gastrointestinal Microflora in Allergic Disease Pathogenesis
Oral Bacteria and Allergic Diseases
Relationship Between Microbial Exposures and Allergic Disease: Evidence from Animal Models
Immunological Effects of Infections and Microbial Exposures
Probiotics and Other Therapeutic Strategies
1104 – Difficult Cases (Part One)
Food Allergy
Difficult Cases (Part One)
Urticaria/Dermatology
Difficult Cases (Part One)
Allergy Immunotherapy Vaccine Reaction
Difficult Cases (Part One)
Esophageal Gastrointestinal Diseases
9:00am – 5:00pm
1121 – Basic Aeroallergen Course
Introduction to Fungal Aerobiology
Introduction to Pollen Aerobiology
Pollen Morphology
9:00am – 12:00pm
1131 – NIAID Morning Symposium: Dendritic Cells
Moderator
Dendritic Cells and Immune Memory
Function of Plasmacytoid Dendritic Cells
Modulation of Dendritic Cell Trafficking to and From the Airways
T Cell Stimulation or Suppression by Dendritic Cells Competent to Express Indoleamine 2,3 Dioxygenase
NKT Cell Dendritic Cell Interactions
1141 – Clinical Research (CR) Symposium, Part 1: Biotechnology: From Bench to Bedside
Basic Immunology of Biotech Molecules in Clinical Trials: Their Clinical Efficacy and Safety
Nanotechnology and the Future of Clinical Drug Research
Is Your Site in Compliance with Biotechnology Research?
9:00 – 11:00am
1151 – Medical Administrators (MA) Morning Symposium: Risk Management and the Medical Practice
Medical Administrators (MA) Morning Symposium: Risk Management and the Medical Practice
8:00am – 6:00pm
1161 – Advanced Practice Course For Allied Health Professionals
Moderator
Diagnosis and Management of Asthma: Case Based
Diagnosis and Management of Rhinosinusitis: Case Based
Diagnosis and Management of Stinging Insect Allergy: Case Based
Advanced Practice Course For Allied Health Professionals
Advanced Practice Course For Allied Health Professionals
Spirometry Workshop: Case Based
Navigating the AAAAI Annual Meeting
Advanced Practice Course For Allied Health Professionals
Advanced Practice Course For Allied Health Professionals
Diagnosis and Management of Acute & Chronic Urticaria/Angioedema: Case Based
Atopic/Contact Dermatitis: Case Based:
Advanced Practice Course For Allied Health Professionals
7:30 – 11:40am
1181 – ST*AR Morning Symposium
Can Biomedical Research Reduce the Morbidity and Mortality from Allergy and Asthma?
Molecular Mechanisms of Allergic Inflammation
Welcome from the AAAAI President
The Identification of Key Genes Regulating the Allergic Inflammatory Response
The Influence of the Innate Immune Response on the Adaptive Allergic Response: Mast Cells
1481 – Interactive Lunch Session
Research Opportunities for PhDs in Allergy/Asthma Research: NIH
12:15 – 1:45pm
1501 – Clinical Research (CR) Workshop: The ABCs of Clinical Research
Clinical Research (CR) Workshop: The ABCs of Clinical Research
1502 – Clinical Research (CR) Workshop: How Do You Identify, Develop and Retain Your CRC?
The Private Research Center Perspective
1503 – Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?
Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?
Clinical Research (CR) Workshop: Pediatric Clinical Trials: Are You Ready?
1504 – Clinical Research (CR) Workshop: Are You Prepared for the Future of Clinical Research?
Asthma and Inflammatory Testing: What 's New and What 's on the Horizon?
Diversifying Your Clinical Research Center
1505 – Clinical Research (CR) Workshop: Are You Thinking About Starting Clinical Research?
Clinical Research (CR) Workshop: Are You Thinking About Starting Clinical Research?
2:00 – 5:00pm
1601 – Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 2)
Applying Microarrays to Complex Diseases
Pharmacogenetic Approaches in Allergy and Asthma
Understanding Beta2 Adrenergic Receptor Function and Signaling
Genetic Analysis of Populations to Understand the Pathophysiology of Atopy and Asthma
The Nuts and Bolts of Genome – Wide Association Studies
1602 – Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part 2)
Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change
Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change
Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change
Workshop 1: Techniques to Apply to Patients Who are Ready to Change and Sustain Change
Workshop 2: Motivating Patients Who are Reluctant to Change?
Workshop 2: Motivating Patients Who are Reluctant to Change?
1603 – Environmental Effects on Allergic Respiratory Diseases
Risk Factor for Asthma Among Lower Socio – Economic Groups in Baltimore
Endotoxin Exposure in Homes and in the Workplace: For Better or Worse?
Cockroach Allergen and Asthma Morbidity: Results from NCICAS and ICAS
Successful Cockroach Allergen Remediation and Control
Gene – Environment Interactions Influencing the Development of Allergic Respiratory Disease
Multiplex Technology: New Tools for Exposure Assessment and Allergen Specific IgE
1604 – Difficult Cases: (Part 2)
Latex, Occupational and Miscellaneous Allergies
Difficult Cases: (Part 2)
Penicillin Allergy
Difficult Cases: (Part 2)
Rhinitis/Sinusitis/Conjunctivitis
Difficult Cases: (Part 2)
Host Defense Defects
Difficult Cases: (Part 2)
Pediatric Asthma
Difficult Cases: (Part 2)
1605 – Allergy Diagnostics and Immunotherapy: The Nuts and Bolts of an Allergy Practice
1606 – Endoscopic Techniques in Treatment of Sinusitis: Both Pre – and Post – Surgical
Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery
Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery
Anatomy, Radiology, Culture Techniques and Endoscopic Videos in Sinusitis Patients Without Having Surgery
Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies
Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies
Surgery Video – Revision Surgery Video, Endoscopic Videos in Post – Surgical Patients, Case Management Studies
1607 – Set Up & Operation of a Burkard Pollen/Spore Station
Set Up & Operation of a Burkard Pollen/Spore Station
Set Up & Operation of a Burkard Pollen/Spore Station
1608 – Allergic and Immunologic Skin Disorders
Atopic Dermatitis: Etiology from Within
Food Allergen in Atopic Dermatitis
Inhalants and Airborne Irritants and the Atopy Patch Test
Autoimmune Urticaria and Angioedema: Update on Diagnosis and Treatment
1621 – Food Allergy is an International Disease: Regional Differences from Around the World
Common and Specific Food Allergens in Asia
Hot Topics of Food Allergy in Europe
Countermeasures Against Food Allergy in Japan
1631 – NIAID Afternoon Symposium: Immunologic Basis of Food Allergy
Animal Models of Eosinophilic Gastrointestinal Disease and Food Allergy
Genetics of Food Allergy
Pathophysiology of Food – Induced Anaphylaxis
Mechanisms of Innate and Adaptive Immunity to Food Allergens
High Dose Food Allergen in Infancy to Prevent Food Allergy
New Therapeutics for Food Allergy
1641 – Clinical Research (CR) Symposium: All That Glitters is Not Gold: What Can Go Wrong in Clinical Trials
Is Your Clinical Site Financially Successful?
I Have a Contract and I 'm Indemnified so I 'm OK.....or Am I?
Clinical Trial Jeopardy
Clinical Trial Jeopardy
Clinical Trial Jeopardy
2:00 – 4:00pm
1651 – Medical Administrators (MA) Afternoon Symposium: Coding Update for the Allergy Practice
Medical Administrators (MA) Afternoon Symposium: Coding Update for the Allergy Practice
1671 – Launching a Career in Academic Allergy/Immunology
Preparation for an Academic Center
Initial Steps for Success
Launching a Career in Academic Allergy/Immunology
Launching a Career in Academic Allergy/Immunology
Launching a Career in Academic Allergy/Immunology
Launching a Career in Academic Allergy/Immunology
Launching a Career in Academic Allergy/Immunology
Launching a Career in Academic Allergy/Immunology
6:30 – 8:30pm
1901 – Spectrum of Satisfaction in the Treatment of Allergic Rhinitis
Allergic Rhinitis: The Burden of the Disease
Pathophysiology of Allergic Rhinitis and Comorbid Conditions
Current and Emerging Therapies: Achieving Optimal Results
1902 – CSI for Chronic Idiopathic Urticaria: Uncovering a Path of Relief for Our Youngest Patients
Pathophysiology of Chronic Idiopathic Urticaria: Uncovering the Evidence
1903 – Nasal Steroids: Understanding the Differences
Nasal Steroid Options: How Do They Differ?
Evaluating Safety of Intranasal Steroids
1904 – Hereditary and Acquired Angioedema
The Differential Diagnosis and Current Management of Angioedema
Hereditary Angioedema: New Treatments in Sight?
Saturday, February 24, 2007
7:00 – 8:00am
2001 – Pay for Performance: What It Means for the Practicing Allergist
Pay for Performance: What It Means for the Practicing Allergist
Pay for Performance: What It Means for the Practicing Allergist
Pay for Performance: What It Means for the Practicing Allergist
2011 – Mast Cell and Basophil Phenotypic Aberrations and Their Potential Role in "Idiopathic" or IgE – Independent Allergic Diseases
2012 – Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions
Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions
Aspirin Exacerbated Respiratory Disease (AERD) and Other NSAID Reactions
2013 – What is the Role of Leukotriene Antagonists in Respiratory Disease?
What is the Role of Leukotriene Antagonists in Respiratory Disease?
What is the Role of Leukotriene Antagonists in Respiratory Disease?
2014 – Environmental Control for Management of Allergic Asthma
Environmental Control for Management of Allergic Asthma
Environmental Control for Management of Allergic Asthma
2015 – Evidence – Based Use of IVIG in PID
Evidence – Based Use of IVIG in PID
Evidence – Based Use of IVIG in PID
2016 – Exposure to Bioaerosals: Does it Drive the Allergic Process?
Exposure to Bioaerosals: Does it Drive the Allergic Process?
Exposure to Bioaerosals: Does it Drive the Allergic Process?
2017 – Insights Gained From the Study of Toll – Like Receptors
Insights Gained From the Study of Toll – Like Receptors
Insights Gained From the Study of Toll – Like Receptors
2018 – Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate
Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate
Assessment of Airway Inflammation Using FENO and Exhaled Breath Condensate
2019 – Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge
Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge
Diagnostic Tests for Food Allergy: Skin, CAP RAST, Oral Challenge
2020 – When to Start and Stop Venom Immunotherapy: Challenging Cases
When to Start and Stop Venom Immunotherapy: Challenging Cases
When to Start and Stop Venom Immunotherapy: Challenging Cases
2021 – Journal Club: High Impact Publications for Health Care Education, Delivery and Quality
Journal Club: High Impact Publications for Health Care Education, Delivery and Quality
Journal Club: High Impact Publications for Health Care Education, Delivery and Quality
2022 – Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways
Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways
Bronchial Hyper – Responsiveness in Asthma: Insights Into New Signaling Pathways
2023 – The Role of Adenosine and Adenine Nucleotides in Asthma and Cough
The Role of Adenosine and Adenine Nucleotides in Asthma and Cough
The Role of Adenosine and Adenine Nucleotides in Asthma and Cough
The Role of Adenosine and Adenine Nucleotides in Asthma and Cough
2024 – Sublingual Immunotherapy: Whom and How?
Sublingual Immunotherapy: Whom and How?
Sublingual Immunotherapy: Whom and How?
2025 – Cytokines and Growth Factors in Ocular Disorders
Cytokines and Growth Factors in Ocular Disorders
Cytokines and Growth Factors in Ocular Disorders
7:00 – 8:15am
2031 – Allergy and Asthma for the Health Care Professional (AAHCP) Symposium: Controversies and Opportunities in Management of Moderate to Severe Persistent Asthma
Pro
Con
2041 – Medical Administrators (MA) Symposium: Staff Recruitment and Retention
Medical Administrators (MA) Symposium: Staff Recruitment and Retention
8:15 – 9:45am
2101 – Immunopathogenesis of Asthma
TSLP: The Master Switch of Allergic Inflammation
Role of Oxidative Stress by Particulate Air Pollution in Asthma Exacerbations
Role of CD – 1 Restricted NKT Cells in Airway Inflammation and Asthma
10:45am – 12:00pm
2301 – New Vaccines: Not Just For Children
Preventing Shingles and Post – Herpetic Neuralgia with Herpes Zoster Vaccine
Adverse Reactions to Vaccines Revealed in Military Populations
HPV Vaccines: Promise and Problems
2302 – Bench to Bedside: Atopic Dermatitis
Cutaneous Defense Mechanisms
Genetics and Epigenetics of AD
Therapeutic Protocols with Immunomodulators for AD
2303 – Mast Cells: Pivotal Regulators of Host Defense
Mast Cells and Host Response to Bacterial Pathogens
Antigen – Independent Effects of IgE on Mast Cells
Mast Cells in Inflammatory Arthritis
2304 – Non – Allergic Asthma: Searching for Causes?
Respiratory Viruses: Causes or Aggravates?
Does Early Exposure to Environmental Tobacco Smoke Contribute to Development of Asthma?
Non – Viral Infections: Causes or Aggravates?
2305 – Air Pollutants as Adjuvants in Allergic Diseases and Asthma: A New Era for the Allergy Specialty
What is the Contribution of Air Pollution to the Causation of Allergic Disease and Asthma?
The Role of Air Pollution Particles as a Potent Adjuvant that Causes Allergic Disease and Asthma?
Can Adverse Respiratory Health Effects of Air Pollutants be Prevented?
2306 – Medical Informatics and the A/I Specialty
Translational Bioinformatics: From Research to Care
Electronic Medical Health Records and Major Directions for Applications
The Use of Computer Systems to Improve Patient Care: Focus on Safety and Quality
2307 – Allergies of the EYE in The Eyes of The Allergist
The Red Eye: Allergy, Dry or Hyperreactive?
Conjunctival Challenge – A Clinical as Well as a Research Tool for the Allergist?
2311 – Allergy and Asthma for the Health Care Professional (AAHCP) Symposium: Chronic Cough: Sorting Out a Common Topic
Children
2321 – Medical Administrators (MA) Morning Symposium: Information Technology: Enhancing Clinical Operations
Medical Administrators (MA) Morning Symposium: Information Technology: Enhancing Clinical Operations
12:30 – 1:30pm
2501 – ADT State–of–the–Art: Asthma Immunopathogenesis: A Pathway For Future Therapy
ADT State–of–the–Art: Asthma Immunopathogenesis: A Pathway For Future Therapy
2502 – BCI State–of–the–Art: Pathogen Recognition Receptors in Inflammation and Immunity
Modulating Vaccine Responses with Dendritic Cells and Pathogen Recognition Receptors
Caterpillers R ' Us: Novel Regulators of Inflammation and Apoptosis Preserved from Plants to Humans
2503 – EORD State–of–the–Art: Gene – Environment Interactions
EORD State–of–the–Art: Gene – Environment Interactions
2504 – FADDA State–of–the–Art: Role of Food Allergy and Patch Testing in Eosinophilic Esophagitis and Gastroenteritis
2505 – HCEDQ State–of–the–Art: Insight Into Disparities in Pediatric Asthma
Preventing Asthma Hospitalizations in Inner – City and Minority Children
2506 – MAAI State–of–the–Art: The Central Role of the TSLP OX40 Ligand Pathway in Polarizing Allergic Immune Responses
MAAI State–of–the–Art: The Central Role of the TSLP OX40 Ligand Pathway in Polarizing Allergic Immune Responses
2507 – RSOD State–of–the–Art: Obstructive Sleep Apnea: Inflammatory Effects
RSOD State–of–the–Art: Obstructive Sleep Apnea: Inflammatory Effects
2511 – Reimbursement Matters: Use the Perfect CPT Codes
Reimbursement Matters: Use the Perfect CPT Codes
Reimbursement Matters: Use the Perfect CPT Codes
2512 – Regulatory T Cells
Regulatory T Cells
2513 – Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?
Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?
Mycoplasma, Pneumococcus and Viral Illness: Their Role in Asthma?
2514 – What is the Best Way to Follow Asthma Control?
What is the Best Way to Follow Asthma Control?
What is the Best Way to Follow Asthma Control?
2515 – Monoclonal Antibody Therapy of Disease
Monoclonal Antibody Therapy of Disease
Monoclonal Antibody Therapy of Disease
2516 – Hypereosinophilia and Eosinophilia Disease
Hypereosinophilia and Eosinophilia Disease
Hypereosinophilia and Eosinophilia Disease
2517 – The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm
The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm
The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm
2518 – Sick Building Syndrome: Does it Really Exist and How Do You Treat It?
Sick Building Syndrome: Does it Really Exist and How Do You Treat It?
Sick Building Syndrome: Does it Really Exist and How Do You Treat It?
2519 – Desensitization Protocols for Antibiotics and Other Medications
Desensitization Protocols for Antibiotics and Other Medications
Desensitization Protocols for Antibiotics and Other Medications
2520 – Chronic Urticaria/Angioedema Update
Chronic Urticaria/Angioedema Update
Chronic Urticaria/Angioedema Update
2521 – Newer Treatment Options in CRS
Newer Treatment Options in CRS
Newer Treatment Options in CRS
2522 – Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans
Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans
Aspirin – Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans
2523 – Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization
Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization
Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization
2524 – Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies
Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies
Nose – Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies
2525 – Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis
Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis
Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment and Prognosis
2:00 – 3:15pm
2621 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Allergic Rhinitis to Asthma: The Spectrum of One Airway Disease
The Role of Upper Airway Disease (Rhinitis/Sinusitis) in the Pathogenesis of Asthma
Therapeutic Interventions for Patients with Both Upper and Lower Airway Disease
2622 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The Stinging Insects: Identification, Patient Evaluation & Treatment
Overview of the Stinging Insects, Their Habitats and Habits
3:30 – 4:30pm
2701 – Keynote Address: Emerging and Re – Emerging Infectious Diseases: The Perpetual Challenge to Global Health
4:45 – 6:00pm
2801 – Primum Non Nocere: Risk/Benefits for Anti – Asthma Therapy
Beta Receptor Polymorphisms
Glucocorticosteroids
2802 – Difficult and Interesting Cases in Asthma
Difficult and Interesting Cases in Asthma
Difficult and Interesting Cases in Asthma
Difficult and Interesting Cases in Asthma
Difficult and Interesting Cases in Asthma
2803 – Pharmacogenetic Responses in Asthma: Is it Time for Genetic Testing?
The Clinical Consequences of Beta – 2 Receptor Polymorphisms
The Genetics of Corticosteroid Responses: State of the Art
Can Understanding Pharmacogenetics Improve Asthma Control?
2804 – Nuances of Pulmonary Function from Asthma to COPD
Nuances of Pulmonary Function from Asthma to COPD
Nuances of Pulmonary Function from Asthma to COPD
Nuances of Pulmonary Function from Asthma to COPD
2805 – Reassessing Impact of Early Environmental Exposures on Development and Prevention of Allergic Disease
Childhood Exposures in Developed Nations: Is There Something Missing?
Probiotics: Is it Time to Start Using Them?
2806 – Smoking Cessation
Adverse Effects of Active and Passive Smoke Exposure on Asthma and Rhinitis
Youth Tobacco Control Research and Activities in the United States: The Current National Landscape
Practical Smoking Cessation Programs in the Office
2807 – How to Perform a Food Challenge
Private Practice Setting
2808 – Drug Allergy: Ask the Experts
Drug Allergy: Ask the Experts
Drug Allergy: Ask the Experts
Drug Allergy: Ask the Experts
Drug Allergy: Ask the Experts
2809 – Anaphylaxis: Recent Advances in Diagnosis and Risk Assessment
Basic Mechanisms in Anaphylaxis
Laboratory Confirmation of Clinically Diagnosed Anaphylaxis
Clinical Tolerance Versus Risk of Future Anaphylaxis Episodes
2810 – Asthma Patient Education, Counseling and Follow – up Care
National Institute of Nursing Research (NINR)
National Institute of Allergy and Infectious Diseases (NIAID)
National Heart, Lung and Blood Institute (NHLBI)?
Federal Liaison Asthma Group
2811 – Non – Invasive Approaches for Studying Upper and Lower Airway Diseases
Exhaled Breath
2812 – The AAAAI Non – Allergic Rhinitis Work Group Report
The AAAAI Non – Allergic Rhinitis Work Group and Its Findings, So Far
Mucosal Inflammation and Non – Allergic Rhinitis. Is It Present or Not?
Are Non – Allergic Rhinitis and Nasal Hyperresponsiveness One and the Same?
Therapeutic Approaches in Non – Allergic Rhinitis: What Works and What Doesn 't
2813 – Inhalant Aeroallergen Skin Test Selection
Inhalant Aeroallergen Skin Test Selection
Inhalant Aeroallergen Skin Test Selection
Inhalant Aeroallergen Skin Test Selection
2814 – Treatment of a Mock Anaphylactic Reaction
Airway Management of Office Emergencies
Management of Non – Airway Related Office Emergencies
Preparing Your Office and Staff for Medical Emergencies: Staff Training and Equipment
4:45 – 6:15pm
2815 – Introductory Rhinolaryngoscopy
Introductory Rhinolaryngoscopy
4:45 – 6:00pm
2816 – Coding and Medical – Legal Update from JCAAI
Advanced Coding Issues in Allergy Practice
Current Legal Issues and Governmental Regulations Affecting Allergy Practice
2821 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Spirometry for the Allied Health Professional
The Basics – From ATS to Interpretation
Advanced Spirometry – Methacholines and Beyond
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Spirometry for the Allied Health Professional
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Spirometry for the Allied Health Professional
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Spirometry for the Allied Health Professional
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Spirometry for the Allied Health Professional
2822 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: A Culturally Competent Approach to Asthma Management with Ethnically and Culturally Diverse Patients
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: A Culturally Competent Approach to Asthma Management with Ethnically and Culturally Diverse Patients
2823 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Atopic Dermatitis: Bed, Bath and Beyond
The Role of Bed and Bath in Atopic Dermatitis
The Beyond of Atopic Dermatitis
2824 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Urticaria and Angioedema
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Urticaria and Angioedema
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Urticaria and Angioedema
2825 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The ABC?s of an Allergy/Asthma Practice
Highlights of Allergy Skin Testing
2826 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Drug Allergy: An Overview
2831 – JACI: Year in Review
JACI: Year in Review
Sunday, February 25, 2007
7:00 – 8:00am
3001 – The ABAI Maintenance of Certification (MOC) Program: What 's New For 2007?
The ABAI Maintenance of Certification (MOC) Program: What 's New For 2007?
3011 – Mast Cell Differentiation and Host Defense
Mast Cell Differentiation and Host Defense
Mast Cell Differentiation and Host Defense
3012 – Latest Developments in Vaccinology
Latest Developments in Vaccinology
Latest Developments in Vaccinology
3013 – Immunodeficiency Disorders and Autoimmunity
Immunodeficiency Disorders and Autoimmunity
Immunodeficiency Disorders and Autoimmunity
3014 – Antimicrobial Proteins in Allergy and Host Defense
Antimicrobial Proteins in Allergy and Host Defense
Antimicrobial Proteins in Allergy and Host Defense
3015 – Which Allergen Control Measures Actually Work?
Which Allergen Control Measures Actually Work?
Which Allergen Control Measures Actually Work?
3016 – Adaptor Molecules in the Amplification of Receptor Mediated Signal Transduction Pathways
Adaptor Molecules in the Amplification of Receptor Mediated Signal Transduction Pathways
Adaptor Molecules in the Amplification of Receptor Mediated Signal Transduction Pathways
3017 – TLR – 9 Agonists: A New Era in Allergy Immunomodulation
TLR – 9 Agonists: A New Era in Allergy Immunomodulation
TLR – 9 Agonists: A New Era in Allergy Immunomodulation
3018 – Hemopoietic Progenitor Cells in Allergic Inflammation: From Bone Marrow to Lung
Hemopoietic Progenitor Cells in Allergic Inflammation: From Bone Marrow to Lung
Hemopoietic Progenitor Cells in Allergic Inflammation: From Bone Marrow to Lung
3019 – Clinical Use of Handheld Computers
Clinical Use of Handheld Computers
Clinical Use of Handheld Computers
3020 – T Cell Tolerance to Inhaled Allergens – A New Therapeutic Approach?
T Cell Tolerance to Inhaled Allergens – A New Therapeutic Approach?
T Cell Tolerance to Inhaled Allergens – A New Therapeutic Approach?
3021 – State–of–the–Art and Future Therapies for HIV
State–of–the–Art and Future Therapies for HIV
State–of–the–Art and Future Therapies for HIV
3022 – Rhinitis and Conjunctivitis: Similarities and Differences
Rhinitis and Conjunctivitis: Similarities and Differences
Rhinitis and Conjunctivitis: Similarities and Differences
3023 – The Dilemma of Adverse Reactions to Food Additives
The Dilemma of Adverse Reactions to Food Additives
The Dilemma of Adverse Reactions to Food Additives
3024 – Update on Imported Fire Ant Allergy and Antigens
Update on Imported Fire Ant Allergy and Antigens
Update on Imported Fire Ant Allergy and Antigens
3025 – The Changing Landscape of Hereditary Angioedema
The Changing Landscape of Hereditary Angioedema
The Changing Landscape of Hereditary Angioedema
7:00 – 8:15am
3031 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Counseling Your Patients on Successful Smoking Cessation
3032 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Food Allergy Management in Schools and Adolescence: The Latest Update
Food Allergy Management in Schools
3033 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Obstructive Sleep Apnea in the Allergic Patient
Recognizing Sleep Disordered Breathing in Your Allergy and Asthma Patient
Management of Allergies and Asthma in the Obstructive Sleep Apnea Patient
3034 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Cultural Competency and the Asthma Patient
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Cultural Competency and the Asthma Patient
3035 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The Red Eye: Is It Allergy?
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The Red Eye: Is It Allergy?
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: The Red Eye: Is It Allergy?
3036 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: A Practical Approach to Food Challenges in the Office Setting
Hands – on Food Challenges
Hands – on Food Challenges
Hands – on Food Challenges
Hands – on Food Challenges
3041 – Allied Health Seminar: When is it Not Asthma?
Allied Health Seminar: When is it Not Asthma?
Allied Health Seminar: When is it Not Asthma?
3042 – Allied Health Seminar: Transition of Adolescents from Pediatric to Adult Care
Adults
3043 – Allied Health Seminar: Strengthening Asthma Coping Mechanisms
Strengthening Asthma Coping Mechanisms
Allied Health Seminar: Strengthening Asthma Coping Mechanisms
3044 – Allied Health Seminar: The Wheezing Infant
The Wheezing Infant
Allied Health Seminar: The Wheezing Infant
8:15 – 9:45am
3101 – Allergen Exposure and Chronic Allergic Disease
Sensitization and Tolerance to Inhalant Allergens
Importance of Allergen Exposure to Inner City Asthma
Sensitivity to Foods as an Aberration of the Normal Tolerant Response
10:45am – 12:00pm
3301 – Are Current Clinical Tests for Airway Inflammation Ready for Prime Time?
Methacholine, Adenosine Monophosphate and Mannitol Challenges
Exhaled Breath Surrogates
3302 – Mechanisms of Neoplasia Underlying Mastocytosis and Hypereosinophilic Syndrome
Mutations of Kit That Underlie Mastocytosis
Tyrosine Kinase Inhibitors in the Treatment of Mastocytosis
3303 – Development of B Cell Memory: How to Survive in the Germinal Center
B Cell Activation in the Germinal Center: Regulated Development of Mature B Cell Responses
Signals Required for B Cell Maturation
3304 – Variables in Clinical Trial Design
Aligning Primary Outcomes of Asthma Clinical Trials to Enhance the Ability to Compare Medications
Is Successful Asthma Management Dependent on the Finding of One, Two or More Outcome Parameters
How Do Baseline Characteristics Alter the Findings of Clinical Trials
3305 – Pandemic Influenza
Molecular Epidemiology of Influenza
Influenza Virology and Vaccine Development
Management of Influenza in Allergic/Immunologic Patients
3306 – Transcription Factors in Allergic Airway Inflammation and Asthma
Transcription Factors Involved in Th2 Differentiation, Allergic Airway Inflammation and Airway Hyperresponsiveness
FoxP3 Transcription Factor in Immune Regulation of Allergic Asthma
The Toll Road to Transcription
3307 – Stopping the Atopic March
Immunologic Susceptibility Towards Allergy in the Newborn
Epidemiologic Characteristics of the Atopic March/ISAAC Perspective
Current and Future Strategies to Stop the Atopic March
3311 – Allergy and Asthma for the Health Care Professional (AAHCP) Symposium: Occupational Exposure in Allergic Disease
Evaluation of Occupational Respiratory Disorders
Treatment and Prevention of Occupational Allergic Diseases
12:30 – 1:30pm
3501 – Strict Allergen Avoidance Speeds Recovery From Food Allergies
Pro
Con
3502 – Now is the Time to Buy an Electronic Medical Record
Con
3503 – Routine Intradermal Skin Testing Offers Benefit in the Diagnosis of Rhinitis and Asthma
3504 – IVIG Should Be Used to Treat Hypogammaglobulinemia Without Specific Antibody Deficiency
Pro
3505 – Pets Prevent Allergic Diseases
3511 – Allergen Exposures and Asthma: New Threats and Approaches in the Inner City
Allergen Exposures and Asthma: New Threats and Approaches in the Inner City
Allergen Exposures and Asthma: New Threats and Approaches in the Inner City
3512 – Allergens and Global Warming: Is It Really a Problem?
Allergens and Global Warming: Is It Really a Problem?
3513 – Evaluation of Specific Antibody Responses to Diagnose PID
Evaluation of Specific Antibody Responses to Diagnose PID
Evaluation of Specific Antibody Responses to Diagnose PID
3514 – TSLP: A Key Initiator of the Allergic Response
TSLP: A Key Initiator of the Allergic Response
TSLP: A Key Initiator of the Allergic Response
3515 – Controversies in Asthma: The Role of Anti – IgE Therapy
Controversies in Asthma: The Role of Anti – IgE Therapy
Controversies in Asthma: The Role of Anti – IgE Therapy
3516 – Airway Remodeling in Asthma
Airway Remodeling in Asthma
Airway Remodeling in Asthma
3517 – Rhinitis Outcomes Measures in Private Practice
Rhinitis Outcomes Measures in Private Practice
Rhinitis Outcomes Measures in Private Practice
3518 – Mechanisms of Neoplasia Affecting Mast Cells and Eosinophils: Pharmacogenetic Approach
Mechanisms of Neoplasia Affecting Mast Cells and Eosinophils: Pharmacogenetic Approach
Mechanisms of Neoplasia Affecting Mast Cells and Eosinophils: Pharmacogenetic Approach
3519 – Mechanisms of Environmentally – Induced Atopy
Mechanisms of Environmentally – Induced Atopy
Mechanisms of Environmentally – Induced Atopy
3520 – Refractory Asthma in Adults
Refractory Asthma in Adults
3521 – Nasal Polyps: What Do We Know and What Do We Do?
Nasal Polyps: What Do We Know and What Do We Do?
Nasal Polyps: What Do We Know and What Do We Do?
3522 – Allergen Immunotherapy Vaccine Prescription Writing
Allergen Immunotherapy Vaccine Prescription Writing
Allergen Immunotherapy Vaccine Prescription Writing
3523 – Early Intervention in Asthma
Early Intervention in Asthma
Early Intervention in Asthma
3524 – Prevention and Natural History of Food Allergy
Prevention and Natural History of Food Allergy
Prevention and Natural History of Food Allergy
3525 – Allergic Reactions to Vaccines and Vaccine Safety: Avoiding and Managing Adverse Effects
Allergic Reactions to Vaccines and Vaccine Safety: Avoiding and Managing Adverse Effects
Allergic Reactions to Vaccines and Vaccine Safety: Avoiding and Managing Adverse Effects
12:30 pm – 1:45 pm
3531 – Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
Allied Health Networking Lunch and Learn
12:30 – 1:45pm
3532 – Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
Allied Health Workshop: Allergy and Asthma Lunch Roundtable Discussions for the NP/PA
2:00 – 3:15pm
3611 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Is it Asthma or COPD?
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Is it Asthma or COPD?
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Is it Asthma or COPD?
3612 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Is it GE Reflux?
3613 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Device Workshop
3614 – Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Practical Consideration for the Administration of Subcutaneous Immunoglobulin: A Hands – on Workshop
Dosing Considerations for Subcutaneous Immunoglobulin Therapy
Hands – on Station: Demonstration of Infusion Pumps
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Practical Consideration for the Administration of Subcutaneous Immunoglobulin: A Hands – on Workshop
Hands – on Station: Demonstration of Needles for Subcutaneous Therapy
Allergy and Asthma for the Health Care Professional (AAHCP) Workshop: Practical Consideration for the Administration of Subcutaneous Immunoglobulin: A Hands – on Workshop
3:30 – 5:30pm
3701 – ADT Interest Section Forum
Welcome and Introduction of Interest Section Leadership
Outside the Box: Clinical Experience with Anti – IgE in the Treatment of ABPA
Mannitol: Will it Replace Conventional Challenges?
The Challenges of Pharmacotherapeutics in the Elderly Asthmatic
Exercise – Induced Bronchospasm in Athletes: Are they being Overtreated?
3702 – BCI Interest Section Forum
ICOS Deficiency and Common Variable Immunodeficiency
3703 – EORD Interest Section Forum
Immunopathogenesis of Occupational Allergy to Laboratory Animals
Occupational Allergy to Laboratory Animals: Who is at Risk and What Can You Do About It?
3704 – FADDA Interest Section Forum: Allergic Reactions to Latex and Drugs, Progress and Challenges
Latex Allergy: A Great Success?
Challenge vs. Desensitization for Drug Allergy: A Practical Approach
3705 – HCEDQ Interest Section Forum: Pay for Performance
The Role of NCQA in the Development of Asthma Performance Measures
What the Performance Measures Mean to the Practicing Allergist
3706 – MAAI Interest Section Forum
Phospho-Proteomic Immune Analysis: From Mechanism to Translational Medicine
From a Shot in the Dark to a Shot in the Arm: Making a TLR-Based Vaccine Against Ragweed
3707 – RSOD Interest Section Forum
Comparison of Evidence for SCIT and SLIT in Allergic Rhinitis
Cough Committee Report
Immunotherapy and Allergy Diagnostics Committee Report
Immuno – Ophthalmology Committee Report
Sublingual Immunotherapy in the US: Cost – Benefit Analysis and Other Pharmacoeconomic Issues
Rhinitis Committee Report
Rhinosinusitis Committee Report
7:30 – 9:30pm
3901 – Issues in the Management of Persistent Asthma: Looking Forward at Inhaled Corticosteroid Therapy
Issues in the Management of Persistent Asthma: Looking Forward at Inhaled Corticosteroid Therapy
3902 – Evolving Practice Guidelines for Immunoglobulin Therapy: Expanding Uses and Patient Management
Immunoglobulin Preparations: Past, Present and Future
Immunoglobulin Therapy in Human Disease
Management of Patients Undergoing Replacement Ig Therapy
3903 – Rhinosinusitis: Differential Diagnosis for Improving Patient Care
The Impact of Inflammation in Rhinosinusitis
Differential Diagnosis: Measurements and Assessment Tools for Improving Patient Care
Rhinosinusitis: Tailoring Treatment Options
3904 – The Brave New World of Aeroallergens
The Enemy Within: Facing Indoor Allergens
New Allergens Worldwide: The Ragweed Example
New Pharmacotherapy for Today?s Aeroallergens: Potent Treatment for Persistent Symptoms
Monday, February 26, 2007
7:00 – 8:00am
4001 – Food and Drug Administration (FDA)
Food and Drug Administration (FDA)
Food and Drug Administration (FDA)
4011 – Impact of Rhinitis on Sleep, Performance and Mood
Impact of Rhinitis on Sleep, Performance and Mood
Impact of Rhinitis on Sleep, Performance and Mood
7:00 – 8:00 am
4012 – Use of Quality of Life Questionnaires in Clinical Research and Healthcare Utilization
Moderators
7:00 – 8:00am
4013 – Use of Current and Future Biologics in the Treatment of Atopic Dermatitis
Use of Current and Future Biologics in the Treatment of Atopic Dermatitis
Use of Current and Future Biologics in the Treatment of Atopic Dermatitis
4014 – Diseases that Mimic EIA
4015 – Bringing Meaning to the Black Box Warning of LABAs
Bringing Meaning to the Black Box Warning of LABAs
Bringing Meaning to the Black Box Warning of LABAs
4016 – Novel Diagnostics in PID and Immunodeficiency Screening in Newborns
Novel Diagnostics in PID and Immunodeficiency Screening in Newborns
Novel Diagnostics in PID and Immunodeficiency Screening in Newborns
4017 – Allergic Occupational Disease Among Health Care Workers: Latex Allergy and Beyond
Allergic Occupational Disease Among Health Care Workers: Latex Allergy and Beyond
Allergic Occupational Disease Among Health Care Workers: Latex Allergy and Beyond
4018 – Electronic Medical Records
4019 – Eosinophilic GI Disorders: Mechanisms, Diagnosis and Management
Eosinophilic GI Disorders: Mechanisms, Diagnosis and Management
Eosinophilic GI Disorders: Mechanisms, Diagnosis and Management
4020 – Nanotechnology, Novel Drug Delivery and Asthma Therapy
Nanotechnology, Novel Drug Delivery and Asthma Therapy
Nanotechnology, Novel Drug Delivery and Asthma Therapy
4021 – Mechanism of Impaired Steroid Function in Structural Cells of the Asthmatic Airways
Mechanism of Impaired Steroid Function in Structural Cells of the Asthmatic Airways
Mechanism of Impaired Steroid Function in Structural Cells of the Asthmatic Airways
4022 – Headaches: Sinuses or What?
4023 – An Allergist 's Perspective on Immunology: Difficult Cases
An Allergist 's Perspective on Immunology: Difficult Cases
An Allergist 's Perspective on Immunology: Difficult Cases
4024 – Practical Management of Diagnosed Food Allergy in Infants and Children
Practical Management of Diagnosed Food Allergy in Infants and Children
Practical Management of Diagnosed Food Allergy in Infants and Children
4025 – Anaphylaxis in the Allergy Office
Anaphylaxis in the Allergy Office
Anaphylaxis in the Allergy Office
8:15 – 9:45am
4101 – Understanding Asthma Risk Factors: Influence of Gender, Age and Obesity
Brief Introduction: Overview of Asthma Risk Factors
Pulmonary Physiology and Measurement: Influence of Gender, Age and Obesity
Obesity as a Risk Factor for Asthma: Mechanisms and Clinical Impact
The Disproportionate Burden of Asthma in Women and the Elderly
10:45am – 12:00pm
4301 – The Interface Between Allergy and Autoimmune Disease
Genes Common to the Pathogenesis of Atopic Dermatitis and Psoriasis
The Hygeine Hypothesis Expanded: Infections in Allergy and Autoimmune Disease
Fox – Family Molecules in Immune Diseases
4302 – Immune and Clinical Factors in Gastrointestinal Disease
Etiology and Therapy for Eosinophilic Esophagitis
Celiac Disease: Advances in Recognition and Diagnosis
Immune Factors in Inflammatory Bowel Disease
4303 – HIV/AIDS: An Update for the Allergist/Immunologist
Pathogenesis and Consequences of Secondary Immunodeficiency in AIDS
AIDS Epidemiology and Progress in Vaccine Development
4304 – Ethical Safeguards in Clinical Research: What Every Clinician Should Know
Vulnerable Populations in Research
Doing Right and Doing Good in Clinical Research
4305 – Role of TNF Alpha in Inflammation and Asthma
TNF as a Therapeutic Target in Rheumatological Disease
The TNF/T Cell/Mast Cell Axis
What is The Role of TNF in Asthma? Is TNF a Suitable Therapeutic Target in Asthma?
4306 – Novel Approaches to Allergen Immunotherapy
Adjuvants and Modified Allergens
Alternate Routes
Conventional Immunotherapy: The Use of Omalizumab as an Adjunct to Immunotherapy
4307 – NHLBI Clinical Research Programs: Asthma Exacerbations: What Do Clinical Studies Tell Us About Defining, Predicting and Preventing Them?
Children Ages 1 – 4: Parental Evaluation of Clinical Predictors of Wheezing in Young Children
Children Ages 5 – 18: Predictors of Exacerbations in a Comparitive Medication Study
Adults: Asthma Control Questionnaire and Respiratory Infections as Predictors of Exacerbations
Genetic Polymorphisms Associated with Exacerbations in Mild – Moderate Asthma
Effect of Early Treatment on Exacerbations Over Time in Children from Age 5 Through Adolescence
3:15 – 4:30pm
4701 – New NAEPP Guidelines for the Management of Asthma: Expert Panel Report 3
Management in Adults
Management of Exacerbations
4:45 – 6:00pm
4801 – Asthma Through the Ages: Childhood, Adult and Elderly Adults
Childhood Asthma: Corticosteroids and the Young Child?
Targeting Controller Therapy in Adults: Disease Control vs. Disease Progression?
Asthma in the Elderly: Is Asthma Related to COPD??
4802 – Approaches to the Management of Mild Asthma Already Controlled with ICS and The Placebo Effect: Results of the ALA 's Asthma Clinical Research Centers ' LOCCS and TAPE Trials
Step – Down Therapy in Mild – Moderate Asthma: What are the Options and What are the Data?
The Placebo Effect in Asthma – What is It? Can it be Measured?
4803 – Inhalation Challenge Tests
4804 – New Developments in Complement Biology
New Developments in Complement Biology?
Complement – Dependent Fetal Loss in Antiphospholipid Syndrome
Pharmacologic Modulation of the Complement Cascade
4805 – Practical Considerations in Subcutaneous IgG Treatment
Practical Considerations in Subcutaneous IgG Treatment
Practical Considerations in Subcutaneous IgG Treatment
Practical Considerations in Subcutaneous IgG Treatment
Practical Considerations in Subcutaneous IgG Treatment
Practical Considerations in Subcutaneous IgG Treatment
4806 – Environmental Interventions: What Works?
Cleaning the Air: What Works?
Environmental Control Practices for Pests: State–of–the–Art
Is Environmental Intervention a Viable Public Health Strategy?
4807 – Intro to Occupational Allergic Disease: How to Navigate Workers ' Compensation Systems and Where to Look for Help
Establishing a Diagnosis of OILD: Why and How?
Immunosurveillance and Prevention of Occupational Lung Disorders
Understanding Workers ' Compensation and Disability: What 's the Difference?
4808 – Consensus Report on Eosinophilic Esophagitis
4809 – Severe Atopic Dermatitis: Focus on the Infant and Toddler: Ask the Dermatologist and Allergist
Panelist
Severe Atopic Dermatitis: Focus on the Infant and Toddler: Ask the Dermatologist and Allergist
Severe Atopic Dermatitis: Focus on the Infant and Toddler: Ask the Dermatologist and Allergist
Severe Atopic Dermatitis: Focus on the Infant and Toddler: Ask the Dermatologist and Allergist
4810 – Controversies in Insect Allergy
Moderator
Panelists
Controversies in Insect Allergy
Controversies in Insect Allergy
4811 – Patch Testing for Contact and Non – Contact Dermatitis
Patch Testing for Contact Dermatitis: True Test and Beyond
Patch Testing for Non – Contact Dermatitis: Where are We Now with Food Patch Testing?
Patch Testing to Drugs: Is There a Role in Non – Immediate Drug Eruptions?
4812 – The Beginning of Asthma: Role of Atrial Natriuretic Peptide Pathway
Biology of Natriuretic Peptide Pathway
ANP Pathway: Modulation of Innate and Adaptive Immunity
Association of ANP – SNP Polymorphism and Asthma
4813 – Testing For and Interpreting Olfactory Abnormalities
Olfactory Abnormalities and How They Relate to Respiratory Disease
Testing For and Interpreting Olfactory Abnormalities
4814 – World Allergy Forum: A Global Perspective on Genetics, the Environment and Allergy
Is Early Exposure to Allergen Protective?
How Does the Environment Influence Genetic Responses?
Environmental Intervention in the Management of Allergic Diseases
4:45 – 6:15pm
4815 – Hands – on Rhinolaryngoscopy
Hands – on Rhinolaryngoscopy
Hands – on Rhinolaryngoscopy
Hands – on Rhinolaryngoscopy
Hands – on Rhinolaryngoscopy
Hands – on Rhinolaryngoscopy
4:45 – 6:00pm
4816 – The New in Pediatric Allergy, Asthma & Immunology
4:30 – 5:30pm
4821 – Immunotherapy Practice Parameters: New Guidelines for Practice?
Immunotherapy Practice Parameters: New Guidelines for Practice?
Immunotherapy Practice Parameters: New Guidelines for Practice?
4822 – Food Challenges in the Office: When and How?
Food Challenges in the Office: When and How?
Food Challenges in the Office: When and How?
4823 – Biogenic Amines in Allergy and Inflammation: New Possibilities for Adjunct Pharmacotherapy
Biogenic Amines in Allergy and Inflammation: New Possibilities for Adjunct Pharmacotherapy
Biogenic Amines in Allergy and Inflammation: New Possibilities for Adjunct Pharmacotherapy
4824 – Use of Quality of Life in Clinical Practice to Increase Patient Adherence and Enhance Patient Satisfaction
4:30 – 6:30pm
4825 – Formula for Success: Connecting with NIH Program Officers
Formula for Success: Connecting with NIH Program Officers
Formula for Success: Connecting with NIH Program Officers
4:45 – 6:00pm
4831 – Hot Topics for 2006
Hot Topics: Basic Science
Hot Topics: Translational
6:30 – 8:30pm
4901 – Novel Strategies to Improve Disease State Management in Asthma
Reasons for Poor Control in Patients with Asthma
Novel Antiasthmatic Strategies to Address Nonresponse and Control?
4902 – Issues in Adherence: Patient and Clinical Perspectives
Patient Reported Outcomes: Satisfaction, Control and Quality of Life?
Controversies and Challenges Surrounding Adherence: A Clinician 's Perspective?
Controversies and Challenges Surrounding Adherence: A Patient 's Perspective
4903 – The New NAEPP Asthma Guidelines: Practical Implications for Clinicians
Moderator
Co – Moderator
Assessing Severity and Control
How to Use the Guidelines in a Busy Clinical Practice?
Allergen Specific Management in the Guidelines?
Tuesday, February 27, 2007
7:00 – 8:00am
5011 – Mast Cell Activation in Flushing Disorders and Systemic Mastocytosis: Mechanisms, Work – up and Management
Mast Cell Activation in Flushing Disorders and Systemic Mastocytosis: Mechanisms, Work – up and Management
5012 – International Asthma Outreach: Gears, Equipment and Parachutes
International Asthma Outreach: Gears, Equipment and Parachutes
5013 – Which Asthmatics are at Risk for Progression and Can This be Prevented?
Which Asthmatics are at Risk for Progression and Can This be Prevented?
Which Asthmatics are at Risk for Progression and Can This be Prevented?
5014 – Demystifying the Evaluation of an Immunodeficient Patient
Demystifying the Evaluation of an Immunodeficient Patient
Demystifying the Evaluation of an Immunodeficient Patient
5015 – Transplantation Immunology for the Practicing Allergist
Transplantation Immunology for the Practicing Allergist
Transplantation Immunology for the Practicing Allergist
5016 – Novel Allergy Therapeutics
Novel Allergy Therapeutics
5017 – Controversies in Immunotherapy: Recombinant vs. Natural Allergens
Controversies in Immunotherapy: Recombinant vs. Natural Allergens
Controversies in Immunotherapy: Recombinant vs. Natural Allergens
5018 – Beta – Lactam Allergy: With or Without Pre – Pen
Beta – Lactam Allergy: With or Without Pre – Pen
Beta – Lactam Allergy: With or Without Pre – Pen
5019 – Diagnosis and Management of Pruritus: Scratching Below the Surface
Diagnosis and Management of Pruritus: Scratching Below the Surface
Diagnosis and Management of Pruritus: Scratching Below the Surface
5020 – AAAAI Web Site
AAAAI Web Site
5021 – Eosinophil – Mast Cell Interactions in Allergic Diseases
Eosinophil – Mast Cell Interactions in Allergic Diseases
Eosinophil – Mast Cell Interactions in Allergic Diseases
5022 – Application of Polychromatic Flow Cytometry to Allergy and Immunology Research
Application of Polychromatic Flow Cytometry to Allergy and Immunology Research
Application of Polychromatic Flow Cytometry to Allergy and Immunology Research
5023 – When to Use Sinus Imaging and With Which Technique: What Abnormal Findings are Meaningful?
When to Use Sinus Imaging and With Which Technique: What Abnormal Findings are Meaningful?
When to Use Sinus Imaging and With Which Technique: What Abnormal Findings are Meaningful?
5024 – The Role of the Nervous System in Rhinitis
The Role of the Nervous System in Rhinitis
The Role of the Nervous System in Rhinitis
5025 – Allergic Rhinitis From the Perspective of the Pharmaceutical Industry: Opportunities and Problems
Allergic Rhinitis From the Perspective of the Pharmaceutical Industry: Opportunities and Problems
Allergic Rhinitis From the Perspective of the Pharmaceutical Industry: Opportunities and Problems
8:15 – 9:45am
5101 – Molecular Scalpels for Immune Modulation
Targeting TNFalpha: New Opportunities in Allergy and Asthma
Targeting T Cell Co – Stimulation: The CD28 Family of Molecules: Risk/Benefit (CTLA4 vs TGN1412)
Targeting B Cells (anti – CD20 vs anti – CD23 vs BAFF/APRIL/TACI) to Modulate Immune Responses
10:45am – 12:00pm
5301 – The Female Genotype and Immunologic Responses
Unique Observations of Asthma in Women
How Women Respond Differently to Vaccines Compared to Men
The Female Genotype: Differences in Response to Treatment of Asthma and Allergy
5302 – Food Allergy: New Observations, Diagnostics and Treatments
New Insights on Prevalence, Risks and Natural Course
Molecular Characterization of Food Allergens: Towards Improved Diagnostics/Treatment
Treatment Strategies: Progress Toward a Cure
5303 – Recent Advances in Drug Hypersensitivity
New Facets of Drug Desensitization
Hapten – Independent T – Cell Drug Reactions: Evidence and Implications
Role of Infection and Metabolic Activation in Drug Allergy
5304 – Lipid Mediators in Pulmonary Immune Responses and Asthma: New Molecules and New Functions
Cyclooxygenase Products in Allergic Pulmonary Inflammation
Sphingosine – 1 – Phosphate in Autoimmunity and Inflammation
Lipoxin and Aspirin – Modified Lipid Mediators: Novel Endogenous Regulators of Inflammation
5305 – What Makes an Allergen Allergenic?
Oxidases Provide a Signal That Augments Allergic Inflammation to Pollens
Endotoxins Can Modulate Allergic Inflammatory Responses
Proteases Modify Allergens for Allergic Inflammation
5306 – NHLBI Clinical Research Programs: Measuring Asthma Impairment and Risk to Determine Response to Therapy: What are the Best Measures?
Defining and Distinguishing Two Domains of Therapeutic Response: Impairment and Risk
How Good are Pulmonary Function Tests for Assessing Impairment and Risk: Adults: Evidence from Asthma Clinical Research Network (ACRN) Trials
Children: Evidence on Spirometry from Childhood Asthma Management Program (CAMP)?
Children: Evidence on IOS Measure from Childhood Asthma Research and Education (CARE) Network
Are Biomarkers Effective in Assessing Impairment and Risk? Evidence From ACRN, CARE and CAMP
5307 – What is the Optimal Treatment for Virus – Induced Wheezing and Asthma?
Effectiveness of Anti – Inflammatory Treatment in the Prevention of Asthma Exacerbations
Targeting Common Respiratory Viruses with Antivirals or Vaccines: Is There Hope?
Molecular Approaches to Antiviral Therapy: What is on the Horizon?
12:30 – 1:30pm
5501 – LABA are the First Choice Add – On Agent
Con
5502 – Chronic Rhinosinusitis Should Be Treated with Antibiotics
5503 – Local Reactions Do Not Predict Systemic Reactions
Pro
Con
5504 – Are Molds a Cause of Non – Allergic Health Problems?
Pro
5505 – Home Environmental Control is an Effective Treatment for Allergies
Pro
Con
3:45 – 5:00pm
5701 – Cutting – Edge Concepts in Atopic Dermatitis: From Th2 Initiation to Defects in Host Defense
TSLP: Master Switch for Allergic Inflammation?
The Role of Cathelicidins in Susceptibility to Eczema Vaccinatum
Loss – of – Function Variants of Filaggrin: The Key to Development of Atopic Dermatitis?
5702 – Sleep: Neuroimmune Regulation of the Host Response
Neuroimmune Mechanisms in Obstructive Airway Disease
The Importance of Sleep in Host Defense
Why Do We Sleep Differently When We Are Infected?
5703 – Neuropeptide VIP in the Etiology of Asthma
VIP Knockout Mice Have Spontaneous Asthma, Reversible by VIP
Skewing the Th1/Th2 Paradigm with VPAC2
5704 – Update on Regulatory T Cells
Regulatory T Cells: Induction and Effector Function
The Nature of Regulatory T Cells in the Context of Allergic Disease
Regulatory T Cells as a Target for Therapy
5705 – Microarray Basics for the Clinical Immunologist/Allergist
Overview DNA/RNA Arrays: What, How and Why?
Microarrayed Allergen Molecules: A Novel Diagnostic Tool
SNP Chip Array to Identify New Targets
5706 – Dealing with Damp Indoor Spaces – – Evaluation, Remediation and Prevention with State–of–the–Art Building Science
Health Effects of a Damp Environment
Non – Invasive Approach to Evaluating Damp Homes or Workplaces
Advances in Building Construction Designed to Prevent Damp Spaces and Other Causes of Indoor Air Pollution
5707 – Food Allergy by the Nose, the Skin or the Mouth
Pollen Food Syndrome
5708 – Chronic Urticaria: When Antihistamines Fail
Overview of Alternative Therapies for Chronic Urticaria
Role of Anti – IgE in CU
5709 – Medical Information Management: Think Globally, Act Locally
National Medical Infomatics Policy
Information Requirements of Pay for Performance
5710 – Nanotechnology, Novel Drug Delivery and Asthma Therapy
Nanotechnology and Biomedical Applications
Nanotechnology and Drug Delivery in Asthma
Environmental & Occupational Safety of Nanoparticles
5711 – Eosinophil – Mast Cell Interactions in Allergic Diseases
Common Themes in Eosinophils and Mast Cells: Basic Science Perspective
Hypereosinophilic Syndrome and Mastocytosis: Clinical Perspective
Asthma: Eosinophil Disease, Mast Cell Disease or Both?
5712 – Amines and Mast Cells
Histamines and Mast Cells: Orchestrating Allergic Inflammation
Serotonin: Novel Tissue Inflammatory Mediator
Storage and Release of Amines by Mast Cells: Why Do Men and Mice Differ?
5713 – Development and Natural History of Chronic Rhinosinusitis and Nasal Polyps
Natural History
Cytokines in Chronic Rhinosinusitis and Nasal Polyps
ASA/NSAIDs, Chronic Rhinosinusitis and Nasal Polyps
5714 – Chronic Sinus Disease
5715 – The Nuts and Bolts of Obstructive Sleep Apnea
Medical Overview of Sleep Disorders Including Diagnosis
Association of OSA with Asthma and Allergic Rhinitis: Mediation by Obesity and Inflammation
Medical and Surgical Rx of OSA
5716 – Clinical Updates from the American College of Physicians